intracellular
antibodi
technolog
mani
applic
proteom
studi
potenti
intracellular
antibodi
systemat
studi
proteom
made
possibl
develop
new
experiment
strategi
allow
select
antibodi
condit
intracellular
express
intracellular
antibodi
captur
technolog
iact
vivo
twohybridbas
method
origin
develop
select
antibodi
readili
fold
ectop
express
iact
use
rapid
effect
identif
novel
antigen
antibodi
pair
intracellular
compart
vivo
identif
epitop
recogn
select
intracellular
antibodi
iact
open
way
use
intracellular
antibodi
technolog
largescal
applic
proteom
present
format
use
howev
somewhat
limit
need
preselect
input
phage
antibodi
librari
protein
antigen
construct
antibodi
librari
mice
immun
target
protein
provid
enrich
input
librari
compens
suboptim
effici
transform
yeast
cell
enrich
step
requir
express
correspond
protein
repres
sever
bottleneck
scale
technolog
describ
construct
singl
pot
librari
intracellular
antibodi
splint
librari
scfv
fragment
express
directli
yeast
cytoplasm
format
antigenspecif
intrabodi
isol
directli
gene
sequenc
manipul
whatsoev
correspond
protein
describ
also
isol
splint
panel
intrabodi
number
differ
protein
applic
splint
genomewid
scale
help
systemat
studi
function
organ
cell
proteom
explos
growth
amount
data
come
current
highthroughput
genom
proteom
methodolog
call
develop
novel
tool
studi
protein
function
proteinprotein
interact
one
fundament
problem
function
genom
find
gener
techniqu
interfer
protein
protein
protein
dna
interconnect
complex
regulatori
signal
network
intracellular
antibodi
biocca
et
al
shown
valuabl
tool
studi
numer
aspect
biolog
process
open
new
experiment
opportun
analyz
function
wide
rang
cellular
molecul
richardson
marasco
cattaneo
biocca
intracellular
antibodi
intrabodi
exhibit
highli
specif
molecular
recognit
properti
also
abl
modul
function
cognat
target
highli
specif
manner
antibodi
express
insid
cell
alreadi
demonstr
impress
potenti
intracellular
inhibitor
cochet
et
al
biocca
et
al
gargano
et
al
levymintz
et
al
mhashilkar
et
al
intrabodi
concept
base
phenotyp
knockout
intracellular
protein
exploit
specif
target
antibodi
subcellular
compart
intrabodi
deriv
virtual
unlimit
repertoir
antibodi
basic
limit
choic
target
molecul
strategi
inactiv
specif
intracellular
protein
develop
among
rna
interfer
rnai
gener
grow
interest
rnai
approach
howev
limit
incomplet
rna
cleavag
inaccess
rna
sequenc
protein
long
halflif
addit
rnai
use
target
specif
individu
protein
protein
interact
posttransl
modif
protein
intracellular
antibodi
possibl
develop
reagent
prevent
particular
associ
spare
other
last
least
intrabodi
develop
abl
inhibit
cellular
function
provid
direct
biochem
handl
recogn
protein
bind
partner
intrabodi
therefor
great
ad
valu
function
proteom
studi
proteinprotein
interact
notwithstand
success
potenti
bottleneck
protein
knockout
technolog
becam
evid
biocca
et
al
cattaneo
biocca
antibodi
present
natur
synthet
antibodi
repertoir
appear
perform
well
express
intracellularli
due
call
disulphid
bond
problem
moreov
becam
clear
good
intracellular
antibodi
requir
concomit
optim
complex
list
properti
includ
stabil
vivo
halflif
solubl
propens
aggreg
affin
specif
cattaneo
biocca
good
intracellular
antibodi
defin
antibodi
abl
fold
toler
condit
found
cell
cytoplasm
affin
high
enough
interact
effect
target
antigen
rather
attempt
ration
engin
antibodi
properti
show
recent
vivo
select
process
appli
rapidli
effect
select
intrabodi
sever
target
visintin
et
al
visintin
et
al
tse
et
al
yeast
twohybridbas
technolog
name
intracellular
antibodi
captur
technolog
iact
visintin
et
al
prove
valuabl
method
select
intracellular
antibodi
basi
abil
bind
antigen
intracellularli
importantli
other
show
select
antibodi
iact
good
reliabl
predictor
reliabl
intrabodi
mammalian
cell
visintin
et
al
visintin
et
al
tse
et
al
develop
iact
may
therefor
overcom
sever
bottleneck
limit
exploit
intracellular
antibodi
technolog
choic
largescal
protein
knockout
studi
cell
therefor
function
proteom
therefor
import
optim
select
procedur
isol
valid
intracellular
antibodi
remov
residu
limit
present
select
technolog
present
implement
iact
use
sourc
antibodi
variabl
region
gene
independ
gener
fig
repertoir
good
intracellular
antibodi
subset
total
antibodi
repertoir
larg
size
librari
togeth
limit
effici
dna
transform
yeast
cell
requir
intracellular
select
step
requir
necessarili
preselect
enrich
step
order
reduc
size
input
librari
complex
compat
downstream
express
yeast
cell
inde
make
intracellular
antibodi
librari
iact
select
v
gene
might
deriv
lymphocyt
may
undergon
antigen
stimul
vascotto
et
al
submit
public
result
phage
antibodi
librari
select
visintin
et
al
former
case
antigen
immun
repres
enrich
step
vascotto
et
al
submit
public
latter
case
one
cycl
vitro
pan
antigen
column
requir
visintin
et
al
highthroughput
gene
intrabodi
approach
would
requir
immun
preselect
bypass
solut
imped
mismatch
limit
would
creat
librari
enrich
sourc
good
intracellular
antibodi
one
way
would
exploit
intracellular
consensu
sequenc
ic
identifi
sequenc
antibodi
select
iact
visintin
et
al
requir
construct
ad
hoc
engin
ad
hoc
librari
pose
concern
whether
provid
necessari
divers
explor
paper
possibl
exploit
repertoir
natur
v
region
supersed
need
framework
consensu
engin
plan
construct
intracellular
antibodi
librari
import
paramet
consid
divers
affin
rang
relationship
exist
paramet
antibodi
librari
exist
complex
compar
natur
immun
system
mammal
theoret
repertoir
complet
everi
imagin
antibodi
may
deriv
gener
larger
librari
higher
chanc
isol
specif
antibodi
good
bind
characterist
term
affin
perelson
oster
griffith
et
al
shown
librari
contain
independ
clone
yield
antibodi
protein
affin
low
micromolar
fig
diagram
construct
splint
librari
antibodi
variabl
region
clone
directli
nonimmun
mous
vector
express
activ
domain
two
nl
fuse
tandem
scfv
antibodi
fragment
splint
librari
insert
yeast
strain
episom
form
use
iact
screen
immedi
transform
antigen
use
bait
rang
similar
obtain
primari
immun
respons
vivo
larger
antibodi
librari
clone
yield
specif
antibodi
affin
nanomolar
rang
similar
obtain
secondari
immun
respons
griffith
et
al
vaughan
et
al
sheet
et
al
also
obviou
real
divers
librari
must
take
account
number
correctli
assembl
scfv
number
frame
shift
delet
stop
codon
present
v
gene
sequenc
qualiti
relat
factor
knappik
et
al
therefor
import
paramet
divers
function
antibodi
librari
rather
nomin
divers
librari
paramet
must
evalu
librari
construct
inde
nonfunct
antibodi
fragment
drastic
lower
true
size
librari
normal
evalu
count
number
coloni
dna
transform
affin
rang
requir
intrabodi
librari
refer
valu
provid
interact
affin
protein
involv
eukaryot
signal
transduct
pathway
exampl
affin
prorich
peptid
sequenc
domain
rel
weak
dalgarno
et
al
zucconi
et
al
suggest
intracellular
inhibitor
would
need
high
affin
compet
ligand
interact
motif
demonstr
intracellular
antibodi
affin
rang
nm
could
effect
divert
target
antigen
natur
intracellular
environ
therebi
inhibit
visintin
et
al
gener
intracellular
antibodi
affin
micromolarnanomolar
rang
shown
effect
intracellular
inhibitor
cattaneo
biocca
fact
choos
antibodi
base
higher
affin
vitro
alon
poor
predictor
function
intrabodi
vivo
halflif
stabil
intracellular
antibodi
shown
relev
good
intracellular
inhibit
affin
per
se
zhu
et
al
rajpal
turi
arafat
et
al
addit
precis
subcellular
target
antibodi
increas
local
concentr
two
interactor
compens
lower
affin
final
one
could
expect
antibodi
domain
aggreg
fold
poorli
express
intracellularli
would
provid
growth
disadvantag
cell
express
cardinal
et
al
would
provid
baselin
antigenindepend
select
good
intrabodi
antigendepend
select
scheme
could
superimpos
visintin
et
al
tse
et
al
altogeth
consider
suggest
possibl
librari
size
compat
effici
transform
yeast
cell
larg
enough
select
specif
intracellular
antibodi
vivo
knockout
studi
describ
design
construct
analysi
select
singl
pot
librari
intrabodi
splint
describ
applic
acceler
proteom
program
parallel
studi
vascotto
et
al
submit
public
librari
v
region
deriv
hyperimmun
spleen
mice
immun
rotaviru
protein
creat
select
intracellular
antibodi
iact
select
character
librari
gave
unexpect
result
mani
antibodi
isol
sequenc
antibodi
v
region
obtain
antigen
select
often
similar
germlin
sequenc
vh
vk
ii
antibodi
librari
obtain
immun
splenocyt
also
found
contain
mani
antibodi
differ
antigen
immun
made
iii
select
intrabodi
found
promiscu
high
specif
moreov
iac
technolog
shown
previous
one
anecdot
exampl
lead
isol
put
intracellular
binder
start
directli
small
antibodi
librari
clone
twohybrid
vector
portnertaliana
et
al
librari
preselect
author
show
use
iac
technolog
possibl
select
one
specif
vivo
binder
target
antigen
although
function
character
select
intracellular
antibodi
provid
basi
result
well
basi
consider
made
previou
section
explor
possibl
small
systemat
wellexamin
naiv
librari
antibodi
directli
clone
twohybrid
vector
could
yield
good
singl
pot
librari
intracellular
binder
clone
scheme
use
creat
scfv
librari
outlin
fig
natur
v
region
clone
total
rna
extract
lymphocyt
pool
three
mous
spleen
cdna
synthesi
perform
random
hexam
prime
v
region
amplifi
use
set
partial
degener
orlandi
et
al
suitabl
redesign
sblattero
bradburi
v
region
cdna
also
reamplifi
add
extra
restrict
site
assembl
scfv
fragment
vh
vl
gene
mix
assembl
togeth
scfv
format
overlap
extens
pcr
sheet
et
al
scfv
assembl
librari
subclon
express
fusion
plasmid
fig
bulk
dna
librari
extract
f
clone
transform
yeast
cell
gener
popul
use
readili
select
intracellular
antibodi
differ
antigen
use
vivo
twohybrid
system
clone
effici
close
confirm
pcr
amplif
randomli
isol
bacteri
yeast
clone
data
shown
one
hundr
independ
antibodi
chosen
random
analyz
sequenc
separ
amplifi
vh
vl
gene
fingerprint
restrict
enzym
bstni
analyz
clone
display
differ
sequenc
fingerprint
pattern
confirm
divers
librari
examin
deduc
amino
acid
sequenc
randomli
pick
clone
show
differ
compris
varieti
differ
subgroup
germlin
sequenc
data
shown
verifi
whether
could
select
librari
intracellular
antibodi
signal
protein
intracellular
protein
screen
librari
panel
differ
bait
tabl
includ
two
domain
shc
kra
syk
ubiquit
lymphoid
amyloid
h
gephyrin
tfiii
orf
sarscov
protein
bait
chosen
valid
splint
librari
includ
protein
differ
speci
viral
origin
differ
function
cellular
locat
two
differ
domain
human
shc
adaptor
protein
ventura
et
al
contain
uniqu
aminotermin
prolinerich
region
phosphotyrosin
bind
domain
ptb
follow
collagen
homolog
domain
coohtermin
domain
virtu
ptb
domain
shc
protein
link
receptor
nonreceptor
tyrosin
kinas
activ
downstream
cytoplasm
effector
bind
activ
receptor
tyrosinephosphoryl
protein
implic
pathway
activ
environment
stress
regul
lifespan
human
kra
monomer
membraneloc
small
kda
g
protein
function
molecular
switch
cytoplasm
nuclear
signal
ehrhardt
et
al
rassignal
pathway
attract
target
anticanc
therapi
import
role
carcinogenesi
syk
proteintyrosin
kinas
implic
varieti
haematopoiet
cell
respons
particular
immunoreceptor
signal
event
mediat
divers
cellular
respons
includ
prolifer
differenti
phagocytosi
syk
appear
also
play
gener
physiolog
function
wide
varieti
cell
includ
neuron
cell
suggest
play
import
role
signal
step
neurit
extens
yanagi
et
al
thymosin
encod
ubiquit
actinbind
protein
demonstr
capac
inhibit
neutrophil
infiltr
splicevari
limit
lymphoid
tissu
shown
express
activ
dendrit
epiderm
cell
intraepitheli
lymphocyt
downregul
local
inflamm
girardi
et
al
fig
construct
splint
mous
v
gene
amplifi
degener
primer
total
cdna
second
pcr
gener
product
common
tail
common
end
allow
assembl
full
scfv
gene
common
allow
clone
linear
vector
bsshii
nhei
restrict
site
fig
splint
vector
vector
use
express
splint
librari
fusion
activ
domain
gene
permit
mainten
plasmid
select
media
lack
leucin
yeast
strain
bla
gene
permit
select
plasmid
ecoli
pmicbd
vector
deriv
use
strong
alcohol
dehydrogenas
promot
express
bait
protein
fusion
dnabind
protein
lexa
plasmid
contain
select
marker
origin
replic
allow
propag
yeast
chloramphenicol
resist
gene
cam
allow
select
e
coli
codon
cgc
aaa
lexa
within
mutat
ggc
gaa
respect
gener
mutlexa
convert
gephyrin
protein
copurifi
glycin
receptor
glyr
found
local
postsynapt
side
glycinerg
synaps
prior
et
al
sassoepognetto
fritschi
craig
lichtman
beta
amyloid
ah
major
constitu
senil
plaqu
alzheim
diseas
peptid
gener
famili
differenti
splice
transmembran
domain
tm
contain
protein
call
app
endoproteolyt
process
amyloid
h
peptid
may
central
pathogenesi
ad
sinha
lieberburg
tfiii
induc
multifunct
transcript
factor
activ
respons
varieti
extracellular
signal
transloc
nucleu
turn
signalinduc
gene
roy
sever
acut
respiratori
syndrom
sar
lifethreaten
form
atyp
pneumonia
sarscov
genom
f
kb
long
contain
open
read
frame
orf
flank
region
coronavirus
encod
number
nonstructur
protein
nonstructur
protein
vari
wide
among
differ
coronaviru
speci
unknown
function
seem
dispens
viru
replic
rota
et
al
snijder
et
al
zeng
et
al
dna
sequenc
code
protein
fuse
lexa
protein
creat
antigenspecif
bait
introduc
transform
yeast
cell
express
splint
librari
iact
select
perform
describ
visintin
et
al
note
manipul
whatsoev
correspond
protein
perform
doubl
transform
select
histidin
prototropi
lacz
activ
search
antigenbind
scfv
fragment
lacz
differ
clone
antigen
analyz
secondari
twohybrid
screen
except
ah
gephyrin
tfiii
tabl
secondari
screen
exhaust
lacz
differ
clone
specif
bind
clone
obtain
case
demonstr
baitspecif
singlechain
antibodi
could
express
cytoplasm
nucleu
yeast
cell
fig
tabl
subsequ
secondari
screen
confirm
true
posit
could
identifi
interact
specif
origin
bait
lexa
fusion
lexalamin
eight
clone
clone
kra
syk
gephyrin
ah
tfiii
orf
sarscov
identifi
interact
antigen
interact
unrel
lexalamin
bait
fig
subset
antibodi
fragment
obtain
screen
also
analyz
bind
lymphoidspecif
thymosin
encod
sixresidu
extens
rel
ubiquit
form
thymosin
order
verifi
whether
would
possibl
isol
scfv
specif
lymphoid
form
chose
screen
five
antibodi
fragment
shown
differ
amino
acid
sequenc
among
scfv
isol
test
abil
bind
scfv
test
result
highli
specif
lymphoid
form
fail
bind
ubiquit
one
fig
parallel
select
splint
result
stringent
differ
fingerprint
pattern
found
among
analyz
clone
moreov
shown
select
splint
bait
abl
isol
fig
select
specif
interact
scfv
ag
pair
primari
transform
pool
transform
splint
librari
antigen
contain
yeast
strain
cotransform
librari
plate
medium
select
activ
report
gene
coloni
aris
select
plate
test
activ
lacz
gene
posit
clone
lacz
use
pcr
amplif
scfvbase
primer
amplifi
product
use
bstni
fingerprint
analysi
scfv
whose
amino
acid
sequenc
correspond
scfv
previous
isol
thu
indic
select
splint
exhaust
enough
fish
specif
antibodi
form
thymosin
protein
result
summar
tabl
show
target
protein
chosen
number
differ
antigenspecif
antibodi
could
isol
directli
gene
sequenc
procedur
experiment
optim
refin
robust
rapid
effici
situat
may
use
push
select
condit
fish
strong
binder
improv
stringenc
select
aim
engin
modifi
lexa
bait
bacteri
lexa
protein
vector
modifi
mlexa
abolish
intrins
nl
previous
describ
rhee
et
al
fig
modifi
format
nl
provid
antibodi
prey
vector
verifi
whether
would
possibl
screen
splint
also
antigen
express
yeast
cytoplasm
case
vector
chose
protein
kra
target
antigen
choic
ra
also
due
appar
difficulti
isol
intracellular
antibodi
standard
select
procedur
tabl
modifi
select
procedur
interact
antigen
scfv
must
occur
cytoplasm
antigen
express
yeast
cell
without
intrins
nuclear
local
signal
lexa
scfv
antigen
interact
cell
cytoplasm
complex
transloc
nucleu
activ
transcript
fig
tri
parallel
select
anti
kra
antibodi
lexabait
fusion
protein
without
nuclear
local
signal
case
obtain
number
function
anti
kra
intracellular
antibodi
indic
technolog
modifi
format
allow
select
scfv
affin
high
enough
bring
antibodi
antigen
complex
nucleu
activ
transcript
report
gene
gener
comment
select
kra
either
without
nl
gave
posit
clone
compar
antigen
tabl
note
posit
clone
also
obtain
report
iact
select
strategi
ra
use
bait
might
indic
antigen
diffi
fig
scfv
fragment
specif
recogn
fail
recogn
bait
thymosin
famili
small
protein
entir
compos
singl
domain
f
actin
monomerbind
motif
found
mani
differ
regul
actin
cytoskeleton
lymphoidspecif
thymosin
encod
extrasixresidu
extens
five
antibodi
fragment
obtain
screen
test
abil
bind
shown
figur
scfv
test
result
specif
lymphoid
form
ubiquit
one
culti
enter
nucleu
difficulti
interfer
normal
select
procedur
altern
interfer
endogen
ra
protein
select
antibodi
possibl
due
expect
anti
prolif
effect
anti
ra
antibodi
might
explain
low
number
coloni
obtain
select
case
prevent
success
isol
function
binder
even
difficult
case
discuss
pass
iac
select
funnel
strong
reliabl
predictor
vivo
perform
antibodi
inde
iact
select
predict
properti
function
intrabodi
case
visintin
et
al
tse
et
al
fact
function
intrabodi
screen
much
better
predictor
vitro
scfv
character
case
order
provid
addit
support
valid
splint
librari
describ
bind
properti
antibodi
select
splint
also
confirm
vitro
elisa
one
signific
exampl
one
antigen
antibodi
group
report
antiamyloid
h
antibodi
fig
character
extend
number
icab
select
splint
vivo
perform
express
mammalian
cell
show
good
solubl
halflif
data
shown
conclus
establish
function
antigenspecif
icab
select
natur
larg
tantigen
nuclear
local
signal
nl
b
bacteri
lexa
protein
modifi
mutlexa
abolish
intrins
nl
fuse
target
antigen
without
nl
strategi
test
protein
fuse
mutlexa
recogn
scfv
cytoplasm
complex
ag
scfv
enter
cell
nucleu
activ
report
gene
express
splint
librari
wide
spectrum
differ
protein
antigen
includ
viral
protein
describ
evolut
iact
genet
select
method
allow
isol
function
intrabodi
recogn
gene
product
directli
sequenc
gene
product
without
need
produc
protein
major
goal
work
develop
intracellular
onepot
scfv
librari
suffici
size
divers
facilit
isol
antibodi
everi
conceiv
specif
includ
antibodi
solubl
stabil
affin
properti
suitablesuffici
intracellular
express
import
determin
composit
divers
altern
vitro
immun
system
sourc
antibodi
gene
use
build
block
construct
librari
order
explor
probabl
isol
intrabodi
directli
primari
mous
antibodi
repertoir
engin
singl
pot
antibodi
librari
activ
domain
vector
test
twohybrid
select
strategi
use
wide
panel
differ
antigen
result
obtain
differ
select
perform
indic
splint
librari
good
sourc
antibodi
fragment
abl
bind
protein
intracellularli
fact
possibl
select
sever
scfv
antigen
challeng
iac
technolog
target
antigen
possibl
isol
sever
antibodi
thu
indic
although
proof
principl
splint
librari
complex
f
divers
obtain
still
suffici
isol
antibodi
binder
recogn
particular
antigen
exampl
protein
highli
conserv
speci
well
report
probabl
find
antibodi
given
affin
librari
direct
relationship
size
librari
way
higher
affin
antibodi
select
highli
divers
librari
greater
complex
perelson
oster
requir
divers
select
high
affin
antigenspecif
antibodi
immun
librari
much
lower
requir
select
nonimmun
librari
hand
condit
intracellular
express
allow
antigen
antibodi
pair
achiev
higher
local
concentr
make
affin
would
determin
vitro
import
paramet
good
function
intrabodi
demonstr
rel
small
librari
deriv
natur
repertoir
contain
function
intrabodi
antigen
challeng
therefor
provid
good
sourc
antibodi
suitabl
intracellular
express
splint
librari
construct
engin
whatsoev
murin
v
gene
framework
consensu
engin
cdr
graft
stabl
framework
contrari
previou
expect
enough
wellbehav
intracellularli
stabl
antibodi
small
librari
transform
grown
format
select
function
binder
rel
low
affin
select
condit
yeast
twohybrid
provid
certainli
contrast
wellestablish
observ
visintin
et
al
tse
et
al
high
proport
elisaposit
antigenspecif
scfv
fragment
isol
phage
display
librari
fail
pass
vivo
iact
select
antigen
interpret
result
first
possibl
although
unlik
phage
display
select
antibodi
particularli
unsuit
intracellular
express
oppos
antibodi
directli
deriv
natur
repertoir
intermedi
select
second
unfold
aggreg
antibodi
certainli
provid
growth
disadvantag
cell
like
contribut
background
antigenindepend
select
provid
enrich
function
intrabodi
splint
librari
select
antigendepend
way
third
rel
lower
affin
requir
intrabodi
reduc
size
librari
necessari
isol
intracellular
binder
fourth
well
establish
half
antibodi
express
human
earli
b
cell
compart
polyreact
high
proport
polyreact
antibodi
counterselect
b
cell
differenti
wardemann
et
al
high
frequenc
polyreact
clone
antibodi
popul
use
construct
present
splint
could
part
explain
success
isol
antibodi
antigen
although
secondari
screen
result
see
fig
show
specif
antibodi
inde
readili
found
splint
last
least
possibl
effect
divers
librari
actual
higher
initi
number
yeast
transform
one
scfv
express
given
cell
may
may
result
recombin
event
segreg
differ
scfv
daughter
cell
latter
point
present
care
evalu
could
easili
contribut
increas
effect
divers
factor
select
pressur
iact
may
lead
select
isol
one
antigenspecif
scfv
fragment
futur
experi
address
possibl
larger
splint
librari
could
readili
accomplish
either
directli
scale
present
procedur
recombin
method
carri
yeast
display
antibodi
librari
feldhau
et
al
follow
proof
principl
provid
paper
construct
larg
splint
librari
human
v
region
present
way
iact
combin
splint
allow
direct
select
scfv
suitabl
intracellular
express
obviat
need
preliminari
vitro
phage
antibodi
screen
protein
antigen
need
modif
random
cdr
fix
consensu
framework
base
intracellular
consensu
sequenc
ic
howev
requir
icsbas
engin
v
region
construct
splint
format
could
increas
effect
divers
splint
librari
noteworthi
splint
select
procedur
overcom
protein
express
purif
bottleneck
allow
isol
antibodi
directli
gene
sequenc
protein
manipul
applic
technolog
power
largescal
gener
scfv
specif
cdna
estencod
protein
requir
clone
sequenc
dnabind
domain
vector
chamber
johnston
would
use
especi
function
genom
proteom
program
high
throughput
rapid
system
requir
largerscal
identif
antigen
antibodi
interact
tradit
iact
could
becom
labori
timeconsum
task
posit
clone
must
pick
individu
scfv
dna
must
separ
isol
sequenc
howev
commerci
avail
robot
twohybrid
array
kit
fulli
autom
twohybrid
system
screen
clone
per
day
approach
user
need
sequenc
clone
array
initi
construct
thereaft
sinc
array
use
repeatedli
posit
transform
readili
identifi
without
addit
sequenc
polyreact
antibodi
could
remov
screen
easili
also
improv
consider
inform
deriv
intrabodyv
region
sequenc
thu
develop
valid
intrabodi
databas
vida
contain
larg
number
sequenc
valid
icab
vida
develop
predict
whether
given
antibodi
good
intracellular
antibodi
avail
resourc
http
wwwlaylinegenomicscomvidamageindexhtm
optim
vida
set
allow
facilit
acceler
understand
intracellular
antibodi
properti
thu
allow
rapid
improv
relat
protein
knockout
technolog
believ
develop
splint
librari
use
intracellular
antibodi
intracellular
protein
knockout
greatli
acceler
provid
fulli
valid
antibodi
intracellular
function
make
intracellular
antibodi
technolog
good
complement
interfer
methodolog
includ
wide
use
rnai
method
martienssen
wall
shi
zhang
et
al
howev
intracellular
antibodi
technolog
select
protein
knockout
permit
distinct
advantag
proteom
applic
first
target
protein
instead
rna
bypass
socal
rna
reserv
problem
accord
uncommon
reduct
rna
level
still
result
full
protein
function
due
higher
protein
halflif
second
antibodi
isol
proteinprotein
interact
domain
possibl
select
inhibit
subset
protein
function
leav
other
intact
third
antibodi
use
function
select
scheme
use
downstream
pulldown
isol
recogn
protein
identifi
proteom
mean
fig
gener
sinc
protein
much
closer
biolog
function
correspond
mrna
protein
knockout
methodolog
suitabl
studi
protein
function
splint
librari
repres
optim
sourc
respect
protein
function
interfer
method
mani
way
intrabodi
use
insid
cell
affect
protein
function
apart
block
protein
protein
protein
nucleic
acid
interact
possibl
design
scheme
wherebi
antibodi
bind
antigen
reloc
inappropri
subcellular
locat
traffic
divers
intrabodi
also
employ
inhibit
directli
function
enzym
promot
death
target
cell
induc
mediat
apoptosi
tse
rabbitt
antibodymedi
select
degrad
cellular
protein
target
via
ubiquitin
proteasom
pathway
also
promis
approach
suicid
antibodi
cattaneo
biocca
zhang
et
al
har
cellular
machineri
inhibit
intracellular
protein
function
repres
great
upsid
potenti
whole
intrabodi
approach
believ
intrabodi
technolog
reach
point
scale
largescal
function
proteom
project
deriv
intracellular
antibodi
directli
gene
sequenc
particular
whole
cell
protein
interact
map
present
deriv
aim
isol
antibodi
direct
protein
protein
interact
given
pathway
cell
beyond
reach
splint
librari
repres
essenti
build
block
engin
select
scheme
target
cell
interactom
complet
set
neutral
intrabodi
construct
perform
accord
standard
techniqu
construct
plasmid
follow
clone
strategi
appli
pcr
vk
vh
clone
linker
perform
use
oligonucleotid
sens
antisens
result
pcr
product
digest
ncoi
ligat
ncoidigest
vector
hollenberg
et
al
give
activ
domain
also
reduc
use
templat
amplifi
use
oligonucleotid
sens
antisens
result
pcr
product
digest
nhei
ecori
clone
nhei
ecoridigest
vector
give
construct
plasmid
dnabind
domain
lexa
termin
sequenc
part
gene
isol
bartel
et
al
digest
vector
hindiii
enzym
isol
fragment
clone
hindiiidigest
cam
vector
give
order
inactiv
nuclear
local
signal
rhee
et
al
mutant
wildtyp
lexa
engin
wildtyp
lexawa
mutat
use
primer
sens
antisens
result
pcr
product
digest
hpaipmei
clone
hpai
pmeidigest
vector
give
dna
fragment
pcramplifi
kind
gift
pg
pelicci
clone
ecoribamhi
restrict
site
plasmid
dna
fragment
pcramplifi
clone
ecori
bamhi
restrict
site
plasmid
syk
ecoribamhi
fragment
syk
visintin
et
al
subclon
ecoribamhi
restrict
site
plasmid
kra
bamhipsti
visintin
et
al
subclon
bamhi
psti
restrict
site
respect
dna
fragment
amplifi
vector
gentli
provid
hayday
clone
ecoribamhi
restrict
site
plasmid
dna
fragment
amplifi
vector
gentli
provid
hayday
clone
ecoribamhi
restrict
site
plasmid
dna
fragment
domain
gephyrin
protein
amplifi
rat
gephyrin
gentli
provid
h
betz
clone
ecoribamhi
restrict
site
plasmid
construct
gentli
provid
e
cherubini
dna
fragment
b
amyloid
domain
synthes
primer
anneal
clone
bamhipsti
restrict
site
plasmid
dna
fragment
domain
tfiii
transcript
factor
amplifi
human
tfiii
cdna
clone
bamhi
restrict
site
plasmid
dna
fragment
orf
sarscoronaviru
synthes
primer
anneal
clone
ecorisali
restrict
site
plasmid
clone
sequenc
use
epicentr
sequitherm
excel
ii
kit
alsbyt
mill
valley
ca
licor
automat
sequenc
lincoln
ne
start
select
splint
librari
bait
test
transactiv
report
gene
describ
visintin
cattaneo
bait
result
nontransactiv
thu
use
select
strategi
six
month
mice
euthan
cervic
disloc
prior
spleen
remov
spleen
teas
apart
use
forcep
steril
needl
produc
singl
cell
suspens
lymphocyt
use
immedi
rna
prepar
qiagen
cdna
synthes
use
random
hexam
revers
transcriptas
follow
standard
protocol
vk
vh
region
randomprim
cdna
amplifi
use
modifi
version
primer
describ
orlandi
et
al
vh
vl
gene
reamplifi
add
region
overlap
scfv
linker
well
long
tail
facilit
restrict
enzym
digest
scfv
assembl
mix
equimolar
amount
vh
vl
gene
perform
assembl
previous
describ
krebber
et
al
scfv
obtain
clone
bsshiinheidigest
obtain
librari
f
differ
clone
yeast
cell
splint
librari
transform
yeast
strain
use
rearrang
lithium
acet
transform
protocol
visintin
cattaneo
splint
librari
panel
bait
cotransform
yeast
cell
describ
visintin
cattaneo
visintin
et
al
coloni
isol
histidinedefici
plate
screen
hgal
activ
filter
describ
visintin
cattaneo
visintin
et
al
isol
intrabodi
subclon
plasmid
restrict
site
intrabodi
express
plasmid
sblattero
bradburi
e
coli
grown
jc
h
induct
mm
iptg
al
cultur
supernat
contain
antibodi
fragment
use
elisa
describ
mark
et
al
ninetysixwel
plate
coat
alwel
amyloid
h
peptid
bsa
control
agml
pb
vitro
bind
specif
scfv
determin
elisa
use
target
antigen
bsa
substrat
